FDA takes aim at Houston-based Empower Pharmacy's GLP-1 production
- Posted on September 22, 2026
- By Houston Chronicle
- 0 Views
- 1 min read
In brief
Generating AI summary…
FDA takes aim at Houston-based Empower Pharmacy's GLP-1 production
The FDA took issue with the volume of GLP-1 drugs that Empower produces, suggesting in the warning letter that the changes do not serve legitimate medical needs.